Differences in the immune response to hepatitis B and Haemophilus influenzae type b vaccines in Guatemalan infants by ethnic group and nutritional status

Vaccine

Volumn 27, Issue 27, 2009, Pages 3650-3654

  Asturias, Edwin J ^a,b   Mayorga, Carlos ^c   Caffaro, Carlo ^c   Ramirez, Patricia ^d   Ram, Malathi ^a   Verstraeten, Thomas ^e   Clemens, Ralf ^f   Halsey, Neal A ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b Center for Health Studies   (Guatemala)

^c Department of Pediatrics   (Guatemala)

^d Hospital General San Juan de Dios Guatemala   (Guatemala)

^e GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

^f NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

Author keywords

Haemophilus influenzae type b vaccine; Hepatitis B vaccine; Malnutrition

Indexed keywords

ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS HAEMOPHILUS INFLUENZAE TYPE B HEPATITIS B VACCINE; DIPHTHERIA PERTUSSIS TETANUS VACCINE; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B VACCINE; POLYRIBOSE RIBITOL PHOSPHATE ANTIBODY; UNCLASSIFIED DRUG;

ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG DOSE REGIMEN; ETHNICITY; FEMALE; FEVER; FUSSINESS; GUATEMALA; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS B; HUMAN; HUMAN EXPERIMENT; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOGENICITY; INDIAN; INFANT; INFLUENZA; INJECTION SITE ERYTHEMA; INJECTION SITE REACTION; INJECTION SITE SWELLING; INJECTION SITE TENDERNESS; IRRITABILITY; MALE; MALNUTRITION; NORMAL HUMAN; NUTRITIONAL STATUS; OPEN STUDY; PERTUSSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TETANUS;

ANTIBODIES, BACTERIAL; BACTERIAL CAPSULES; GUATEMALA; HAEMOPHILUS VACCINES; HEPATITIS B ANTIBODIES; HEPATITIS B VACCINES; HUMANS; INFANT; MALNUTRITION;

EID: 67349115984     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.03.035     Document Type: Article

References (22)

1. Montenegro R., and Stephens C. Indigenous health in Latin America and the Caribbean. Lancet 367 9525 (2006) 1859-1869
2. Pan American Health Organization. Health in the Americas 2007. PAHO, Washington, 2007.
3. Ward J.I., Lum M.K., Hall D.B., Silimperi D.R., and Bender T.R. Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis 153 1 (1986) 17-26
4. Santosham M., Rivin B., Wolff M., Reid R., Newcomer W., Letson G.W., et al. Prevention of Haemophilus influenzae type b infections in Apache and Navajo children. J Infect Dis 165 Suppl. 1 (1992) S144-S151
5. Ward J., Brenneman G., Letson G.W., and Heyward W.L. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. N Engl J Med 323 20 (1990) 1393-1401
6. Asturias E.J., Brenneman G.R., Petersen K.M., Hashem M., and Santosham M. Infectious Diseases. In: Rhoades E.R. (Ed). American Indian Health: Innovations in Health Care, Promotion, and Policy (2000), Johns Hopkins University Press, Baltimore, MD 347-369
7. Singleton R., Hammitt L., Hennessy T., Bulkow L., DeByle C., Parkinson A., et al. The Alaska Haemophilus influenzae type b experience: lessons in controlling a vaccine-preventable disease. Pediatrics 118 2 (2006) e421-e429
8. Santos J.I., Martin A., De Leon T., Rivera L., Gaitán M.E., Del Rio C., et al. DTPw-HB and Hib primary and booster vaccination: combined versus separate administration to Latin American children. Vaccine 20 13-14 (2002) 1887-1893
9. Fernández J., Balter S., Feris J., Gómez E., Garib Z., Castellanos P.L., et al. Randomized trial of the immunogenicity of fractional dose regimens of PRP-T Haemophilus influenzae type b conjugate vaccine. Am J Trop Med Hyg 62 4 (2000) 485-490
10. Riedemann S., Reinhardt G., Jara J., Rios R., Wenzel M.S., Willems P., et al. Immunogenicity and reactogenicity of combined versus separately administered DTPw-HBV and Hib vaccines given to healthy infants at 2, 4 and 6 months of age, with a booster at 18 months. Int J Infect Dis 6 3 (2002) 215-222
11. Käyhty H., Eskola J., Peltola H., Rönnberg P.R., Kela E., Karanko V., et al. Antibody responses to four Haemophilus influenzae type b conjugate vaccines. Am J Dis Child 145 2 (1991) 223-227
12. Granoff D.M., Anderson E.L., Osterholm M.T., Holmes S.J., McHugh J.E., Belshe R.B., et al. Differences in the immunogenicity of three Haemophilus influenzae type b conjugate vaccines in infants. J Pediatr 121 2 (1992) 187-194
13. Silfverdal S.A., Ekholm L., and Bodin L. Breastfeeding enhances the antibody response to Hib and Pneumococcal serotype 6B and 14 after vaccination with conjugate vaccines. Vaccine 25 8 (2007) 1497-1502
14. Kurikka S., Käyhty H., Saarinen L., Rönnberg P., Eskola J., and Mäkelä P.H. Comparison of five different vaccination schedules with Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. J Pediatr 128 4 (1996) 524-530
15. Morris S.K., Moss W.J., and Halsey N.A. Haemophilus influenzae type b conjugate vaccine use and effectiveness. Lancet Infect Dis 8 7 (2008) 435-443
16. Steinhoff M.C., Onyango F., Mbori-Ngacha D., and Siber G. The effect of nutritional status on the antibody (Ab) response of Kenyan children to H. influenzae type b (Hib) conjugate vaccine. 31st ICAAC 70 (1991) (Abstract)
17. Doherty J.F., Golden M.H., Griffin G.E., and McAdam K.P. Febrile response in malnutrition. West Indian Med J 38 4 (1989) 209-212
18. Cunningham-Rundles S., McNeeley D.F., and Moon A. Mechanisms of nutrient modulation of the immune response. J Allergy Clin Immunol 115 6 (2005) 1119-1128
19. Arístegui J., Usonis V., Coovadia H., Riedemann S., Win K.M., Gatchalian S., and Bock H.L. Facilitating the WHO Expanded Program of Immunization: the clinical profile of a combined diphtheria, tetanus, pertussis, hepatitis B and Haemophilus influenzae type b vaccine. Int J Infect Dis 7 2 (2003) 143
20. Ropero A.M., Danovaro-Holliday M.C., and Andrus J.K. Progress in vaccination against hepatitis B in the Americas. J Clin Virol 34 Suppl. 20 (2005) S14-S19
21. Ladhani S., Slack M.P., Heys M., White J., and Ramsay M.E. Fall in Haemophilus influenzae serotype b (Hib) disease following implementation of a booster campaign. Arch Dis Child 93 8 (2008) 665-669
22. Goldblatt D. Bacteria, polysaccharides, vaccines and boosting: measuring and maintaining population immunity. Arch Dis Child 93 8 (2008) 646-647